Dr. Zev Munk
Chief Executive Officer
John Hovre
Chief Operating Officer
Madeline Ducate
EVP Global Operations
Eugene Barg
President of MBQ
Yamin Khan
EVP Clinical Development
Dr. Pavle Vukojevic
VP Medical Affairs
James Clark
Chief Financial Officer
Helen Springford
VP Global Client Relations
Yamin Khan PhD, Executive VP Global Clinical Development

As Executive Vice-President of Global Clinical Development, Yamin Khan is responsible for the timely delivery of all Pharm-Olam projects for quality, budget and timelines. As part of Pharm-Olam's continuous drive to offer a better service to its clients Dr. Khan works across projects and clients to identify synergies and share knowledge across the Pharm-Olam project teams.

Yamin has a PhD in Biochemistry and has been in the clinical research industry for over 13 years in small and large CROs and the pharmaceutical industry.
Privacy Policy   |   Clinical Services   |   Regulatory  |   Biostatistics   |   Data Management   |   Pharmacovigilance  |   Therapeutic Experience  |   Rescue Studies  |   Post-Marketing

© 1994 - 2013 Pharm-Olam International. All Rights Reserved.

Argentina (Buenos Aires), Belarus (Minsk), Belgium (Brussels), Brazil (São Paulo), Bulgaria (Sofia), Canada (Toronto), Croatia (Zagreb), Czech Rep. (Prague), Georgia (Tbilisi), Germany (Munich), Hungary (Budapest), India (Bangalore), Italy (Milan), Kazakhstan (Almaty), Mexico (Mexico City), Poland (Warsaw), Romania (Bucharest), Russia (Moscow, St. Petersburg, Novosibirsk), Serbia (Belgrade), Spain (Madrid), South Africa (Johannesburg), Ukraine (Kiev), United Kingdom (London), United States (Houston, Princeton, Research Triangle Park)